In this issue:
Antibody formation predicts anti–TNF-α treatment failure?
Therapeutic trials of psoriasis: changes over time
Fumaric acid esters in psoriasis
Systemic agents: use with care in psoriasis
Pathogenesis of psoriasis by IL-27?
Coal tar: no safety concerns
Goeckerman therapy: genotoxic and apoptotic
MEDI-545 safe in chronic psoriasis
Etanercept benefits in psoriasis
Psoriasis linked to increased risk of CV mortality
Please login below to download this issue (PDF)